UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------------
OMB APPROVAL
---------------------------------
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response.............11
SCHEDULE 13G
Under the Securities and Exchange Act of 1934
(Amendment No.2)*
ORASURE TECHNOLOGIES, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.000001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
68554V 10 8
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2002
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[x] Rule 13d-1(c)
[ ] Rule 13d-1(d)
----------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 68554V 10 8 13G Page 2 of 15 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Ventures V, L.P.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 2,933,207
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 2,933,207
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,933,207
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.81%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 68554V 10 8 13G Page 3 of 15 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Partners V, L.P.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 2,933,207
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 2,933,207
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,933,207
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.81%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 68554V 10 8 13G Page 4 of 15 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
James H. Cavanaugh, Ph.D.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 2,933,207
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 2,933,207
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,933,207
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.81%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 68554V 10 8 13G Page 5 of 15 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Harold R. Werner
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 7,944
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 2,933,207
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 7,944
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 2,933,207
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,941,151
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.83%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 68554V 10 8 13G Page 6 of 15 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
William Crouse
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 97,111
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 2,933,207
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 97,111
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 2,933,207
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,030,318
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.07%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 68554V 10 8 13G Page 7 of 15 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
John W. Littlechild
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 2,933,207
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 2,933,207
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,933,207
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.81%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 68554V 10 8 13G Page 8 of 15 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Christopher Mirabelli, Ph.D.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 2,933,207
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 2,933,207
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,933,207
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.81%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 68554V 10 8 13G Page 9 of 15 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Augustine Lawlor
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 2,933,207
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 2,933,207
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,933,207
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.81%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 68554V 10 8 13G Page 10 of 15 Pages
Item 1(a). Name of Issuer:
Orasure Technologies, Inc.
____________________________________________________________________
Item 1(b). Address of Issuer's Principal Executive Offices:
150 Webster Street
Bethlehem, PA 18015
____________________________________________________________________
Item 2(a). Name of Person Filing:
HealthCare Ventures V, L.P. ("HCV V"), HealthCare Partners V,
L.P. ("HCP V"), Drs. Cavanaugh and Mirabelli and Messrs.
Werner, Littlechild, Crouse and Lawlor. See attached Exhibit
A, which is a copy of their agreement in writing to file this
statement on behalf of each of them.(1)
____________________________________________________________________
Item 2(b). Address of Principal Business Office, or if None, Residence:
The business address for HCV V, HCP V, Dr. Cavanaugh and
Messrs. Werner and Crouse is 44 Nassau Street, Princeton, New
Jersey 08542. The business address for Dr. Mirabelli and
Messrs. Littlechild and Lawlor is One Kendall Square, Building
300, Cambridge, Massachusetts 02339.
____________________________________________________________________
Item 2(c). Citizenship:
HCV V, and HCP V are limited partnerships organized under the
laws of the State of Delaware. Drs. Cavanaugh and Mirabelli
and Messrs. Werner, Littlechild, Crouse and Lawlor are each
United States citizens.
____________________________________________________________________
Item 2(d). Title of Class of Securities:
Common Stock par value $.000001 (the "Shares")
______________________________________________________________
(1) Drs. Cavanaugh and Mirabelli and Messrs. Werner, Littlechild, Crouse
and Lawlor are general partners of HCP V, the general partner of HCV V,
the record holder of the Issuer's Common Stock reported hereto.
CUSIP No. 68554V 10 8 13G Page 11 of 15 Pages
Item 2(e). CUSIP Number:
68554V 10 8
____________________________________________________________________
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a: Not Applicable
(a) [_] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) [_] Investment company registered under Section 8 of the Investment
Company Act.
(e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) [_] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [_] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
CUSIP No. 68554V 10 8 13G Page 12 of 15 Pages
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
As of December 31, 2002: HCV V and HCP V beneficially owned
2,933,207 Shares of the Issuer's Common Stock; Drs. Cavanaugh
and Mirabelli and Messrs. Littlechild and Lawlor each
beneficially owned 2,933,207 Shares; Mr. Crouse beneficially
owned 3,030,318 Shares consisting of 2,933,207 Shares of the
Issuer's Common Stock and options to purchase 97,111 Shares of
the Issuer's Common Stock(2); Mr. Werner beneficially owned
2,941,151 Shares consisting of 2,933,207 of the Issuer's
Common Stock and options to purchase 7,944 Shares of the
Issuer's Common Stock.
______________________________________________________________
(b) Percent of class:
As of December 31, 2002: the 2,933,207 Shares beneficially
owned by HCV V and HCP V constitutes 7.81% of the Shares
outstanding; the 2,933,207 Shares beneficially owned by Drs.
Cavanaugh and Mirabelli and Messrs. Littlechild and Lawlor
constitutes 7.81% of the Shares outstanding; the 3,030,318
Shares beneficially owned by Mr. Crouse constitute 8.07% of
the Shares outstanding; and the 2,941,151 Shares beneficially
owned by Mr. Werner constitutes 7.83% of the Shares
outstanding.
______________________________________________________________
(2) Does not include options to purchase an additional 30,833 Shares of the
Issuer's Common Stock which were granted to Mr. Crouse as a director of
the Issuer and which are not currently exercisable within 60 days of
12/31/02. 3,333 of these options become exercisable as to 1,666.66
Shares per month for 2 months beginning on March 17, 2003, and 27,500
of these options become exercisable as to 2,500 shares per month for 11
months beginning on March 30, 2003. (Mr. Crouse is not deemed to
beneficially own these Shares at the date of this report.)
CUSIP No. 68554V 10 8 13G Page 13 of 15 Pages
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
Mr. Crouse has the sole power to vote or direct the vote as to the
97,111 Shares of the Issuer's Common Stock beneficially owned by him.
Mr. Werner has the sole power to vote or direct the vote as to the
7,944 Shares of the Issuer's Common Stock beneficially owned by him.
(ii) Shared power to vote or to direct the vote:
HCV V, HCP V, Drs. Cavanaugh and Mirabelli and Messrs. Werner,
Littlechild, Crouse and Lawlor share the power to vote or direct the
vote of those Shares owned by HCV V.
(iii) Sole power to dispose or to direct the disposition of:
Mr. Crouse has the sole power to dispose of or to direct the
disposition of the 97,111 Shares of the Issuer's Common Stock
beneficially owned by him.
Mr. Werner has the sole power to dispose of or to direct the
disposition of the 7,944 Shares of the Issuer's Common Stock
beneficially owned by him.
(iv) Shared power to dispose or to direct the disposition of:
HCV V, HCP V, Drs. Cavanaugh and Mirabelli and Messrs. Werner,
Littlechild, Crouse and Lawlor share the power to dispose of or direct
the disposition of those Shares owned by HCV V.
CUSIP No. 68554V 10 8 13G Page 14 of 15 Pages
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities check the following [ ].
Not Applicable
_______________________________________________________________________
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not Applicable.
_______________________________________________________________________
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company or Control
Person.
Not Applicable.
_______________________________________________________________________
Item 8. Identification and Classification of Members of the Group.
Not Applicable.
_______________________________________________________________________
Item 9. Notice of Dissolution of Group.
Not Applicable.
______________________________________________________________________
Item 10. Certifications.
By signing below, I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
Issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
CUSIP No. 68554V 10 8 13G Page 15 of 15 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 3, 2003 HealthCare Ventures V, L.P.
Princeton, New Jersey By: its General Partner, HealthCare Partners V, L.P.
By: /s/ Jeffrey Steinberg
--------------------------------------------
Jeffrey Steinberg, Administrative Partner
February 3, 2003 HealthCare Partners V, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
--------------------------------------------
Jeffrey Steinberg, Administrative Partner
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------
James H. Cavanaugh, Ph.D
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------
Harold Werner
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------
William Crouse
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts --------------------------------------------
John W. Littlechild
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts --------------------------------------------
Christopher Mirabelli, Ph.D.
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts --------------------------------------------
Augustine Lawlor
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree to jointly prepare and file with regulatory
authorities a Schedule 13G and any future amendments thereto reporting each of
the undersigned's ownership of securities of Orasure Technologies, Inc.
Corporation and hereby affirm that such Schedule 13G is being filed on behalf of
each of the undersigned.
February 3, 2003 HealthCare Ventures V, L.P.
Princeton, New Jersey By: its General Partner, HealthCare Partners V, L.P.
By: /s/ Jeffrey Steinberg
--------------------------------------------
Jeffrey Steinberg, Administrative Partner
February 3, 2003 HealthCare Partners V, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
--------------------------------------------
Jeffrey Steinberg, Administrative Partner
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------
James H. Cavanaugh, Ph.D
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------
Harold Werner
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------
William Crouse
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts --------------------------------------------
John W. Littlechild
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts --------------------------------------------
Christopher Mirabelli, Ph.D.
February 3, 2003 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts --------------------------------------------
Augustine Lawlor
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
for whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).